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Abstract
We have previously established that a defect in the ability of alveolar macrophages (AM) to phagocytose apoptotic cells
(efferocytosis) and pathogens is a potential therapeutic target in COPD. We further showed that levels of mannose binding
lectin (MBL; required for effective macrophage phagocytic function) were reduced in the airways but not circulation of
COPD patients. We hypothesized that increased oxidative stress in the airway could be a cause for such disturbances. We
therefore studied the effects of oxidation on the structure of the MBL molecule and its functional interactions with
macrophages. Oligomeric structure of plasma derived MBL (pdMBL) before and after oxidation (oxMBL) with 2,29-azobis(2-
methylpropionamidine)dihydrochroride (AAPH) was investigated by blue native PAGE. Macrophage function in the
presence of pd/oxMBL was assessed by measuring efferocytosis, phagocytosis of non-typeable Haemophilus influenzae
(NTHi) and expression of macrophage scavenger receptors. Oxidation disrupted higher order MBL oligomers. This was
associated with changed macrophage function evident by a significantly reduced capacity to phagocytose apoptotic cells
and NTHi in the presence of oxMBL vs pdMBL (eg, NTHi by 55.9 and 27.0% respectively). Interestingly, oxidation of MBL
significantly reduced macrophage phagocytic ability to below control levels. Flow cytometry and immunofluorescence
revealed a significant increase in expression of macrophage scavenger receptor (SRA1) in the presence of pdMBL that was
abrogated in the presence of oxMBL. We show the pulmonary macrophage dysfunction in COPD may at least partially result
from an oxidative stress-induced effect on MBL, and identify a further potential therapeutic strategy for this debilitating
disease.
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Introduction
Chronic obstructive pulmonary disease (COPD), a lung disease
mostly associated with cigarette smoking, is predicted to be the
third leading cause of death in the world by 2020 [1]. COPD is
incurable, existing treatments are largely symptomatic, and there
is an urgent need for identification of new therapies. Macrophages
are the prominent leucocyte found in lungs. We have shown that a
dysfunction of pulmonary macrophages in COPD may provide a
novel target for therapeutic manipulation [2–4]. In particular, a
significant defect in the ability of pulmonary macrophages to
phagocytose apoptotic epithelial cells (defective efferocytosis)
established in the airways of COPD patients may contribute to
an excess of apoptotic material, secondary necrosis and perpetu-
ation of chronic inflammation [5]. We have also demonstrated
impaired phagocytosis of bacteria in COPD; an important finding
given the increased bacterial colonization and increased suscep-
tibility to infectious exacerbations in these patients [6,7]. These
defects are not isolated to COPD, as we have also reported
increased numbers of apoptotic bronchial epithelial cells and
defective efferocytosis in the airways in other chronic lung diseases
including severe asthma and chronic lung transplant rejection
[8,9]. Importantly, these defects could be substantially overcome
using macrophage-targeted therapies [6,10–14]. In a human phase
II study of COPD subjects we found a significant improvement in
the ability of alveolar macrophages to phagocytose apoptotic
airway epithelial cells and bacteria following treatment with low-
dose azithromycin [6,10,11]. Subsequently, Nakanishi et al
showed that administration of clarithromycin prevented the onset
of emphysema in smoke-exposed mice [15]. Although these results
are exciting and establish the important biological paradigm that
macrophage function can be manipulated for therapeutic gain, the
use of long-term antibiotic therapy has obvious drawbacks
including the potential emergence of antibiotic-resistant strains
of bacteria.
Mannose binding lectin (MBL) is a key component of the innate
immune system produced mostly by hepatocytes for secretion into
circulation. MBL belongs to the family of collectins, which
includes also C1q and lung surfactant proteins. As a soluble
pattern recognition receptor MBL is involved in phagocytosis of
bacteria as well as recognition and clearance of apoptotic cell
bodies [16,17]. Presence of MBL in bronchoalveolar lavage (BAL)
of children with airway infections but not controls suggests its role
in pulmonary defence [18]. We have extensively investigated MBL
in lung diseases, in particular in smokers and COPD patients and
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in a smoke-exposed mouse model [8,12]. Our data showed
significantly reduced levels of functional MBL in the airway of
COPD subjects and healthy smokers compared to non-COPD
controls, and further demonstrated a positive correlation between
efferocytosis and MBL in the airway [8]. Nebulised administration
of plasma derived MBL (pdMBL) significantly restored alveolar
macrophage and lung tissue macrophage efferocytic ability and
reduced airway inflammation in smoke-exposed mice in vivo [12].
These findings strongly support the further study of pdMBL as a
novel macrophage-targeted therapy in COPD. It remains however
to be determined why levels of MBL are low in the airways of
COPD patients while levels in plasma are normal, suggesting a
specific airway-associated effect on MBL.
The molecular structure of MBL includes a basic subunit
consisting of three peptide chains (homotrimer); such homotrimers
can assemble into several oligomeric forms from dimers to
hexamers, thus representing its quaternary structure. It is the
higher order oligomers which are thought to be essential for the
functions of MBL [19]. The quaternary structure may also provide
protection of MBL from susceptibility to metalloproteinase
proteolysis [20]. Given the high levels of oxidative stress that we
and others have reported in COPD/smoker airways [13,21],
oxidative modifications could be hypothesized to disrupt the
quaternary structure of MBL, thus making the molecule both
vulnerable to proteolysis and less efficient in its functional capacity.
This study presents data demonstrating that treatment of native
MBL with a synthetic oxidizing agent led to both disruption of its
higher order oligomeric structures and functional impairment,
assessed by induction of macrophage scavenger receptor A1
(SRA), stimulation of phagocytosis of NTHi and efferocytosis of
apoptotic bronchial epithelial cells by macrophages.
Methods
Antibodies and Reagents
For efferocytosis and phagocytosis assay: CD13 phycoerythrin
cyanine-7 (PE-Cy7) (BD Biosciences, San Jose CA, USA), sytox
orange and sytox green (Molecular Probes, Oregon, USA) were
employed. For other flow cytometry staining: mannose receptor
phycoerythrin (PE) (Immunotech/Coulter, Marseille, France);
Colec-12 unconjugated (R&D Systems, Minneapolis, MN, USA),
detected with anti-goat IgG allophycocyanin (APC) (R&D) and,
CD204 PE (R&D) were employed. For immunofluorescence:
MSR1/SRA unconjugated rabbit polyclonal antibody (Abcam,
Cambridge, UK and sheep anti-rabbit IgG-Cy3, F(ab’)2 fragment
(Sigma-Aldrich, Saint Louis, MO, USA) was employed. All other
reagents, if not otherwise specified, were from Sigma-Aldrich
(Saint Louis, MO, USA).
Bronchoscopy Sampling and Subject Selection
BAL was obtained via flexible bronchoscopy from volunteers as
we have previously reported [2–4]. Ethical approval was granted
by the Royal Adelaide Hospital Ethics Committee and written
informed consent was obtained for each donor of BAL. For in vitro
studies, BAL was collected from 10 healthy adult volunteers with
no history of asthma or allergy and normal lung function.
Preparation of BAL and Purification of Alveolar
Macrophages
BAL was prepared, total cells and macrophages counted and
macrophages purified by adhesion to plastic as previously
described [2–4]. Briefly, for assessment of phagocytosis/efferocy-
tosis and scavenger receptor expression, BAL cells resuspended in
RPMI 1640 media (Gibco, Karlsruhe, Germany) supplemented
with 10% foetal calf serum and 1% penicillin/gentamicin (Gibco)
(hereinafter referred to as R10) were plated at 26105 cells/well on
24-well plates and incubated at 37uC/5% CO2 for 2 h. The plates
were tapped to loosen non-adhered cells which were then gently
removed with the fluid. Alveolar macrophages adhered to the wells
were then replenished with fresh R10 medium for further
experiments.
Preparation of Differentiated THP-1 Macrophages
THP-1 monocytic cells (American Type Culture Collection,
Manassas, VA, USA) growing in continuous culture were
differentiated into macrophages following phorbol myristate
acetate (PMA) stimulation for 72 h as previously reported [4],
and cells treated as described for alveolar macrophages.
Oxidative Modification of Plasma Derived MBL
Affinity purified plasma derived MBL (pdMBL) was obtained
from pooled human plasma as described earlier [12]. Stock of
pdMBL (1 mg/mL in Tris Buffered Saline, TBS) was incubated
with a final concentration of 74 mM of the synthetic oxidizing
agent 2,29-azobis(2-methylpropionamidine) dihydrochloride
(AAPH) (Novachem Pty Ltd, Collingwood, VIC, Australia) for
2 h at 37uC.
Measuring Oxidative Changes to MBL Structure
Samples of pdMBL and its oxidized form (oxMBL) were
analysed by the Adelaide Proteomics Centre, University of
Adelaide, South Australia. Blue native electrophoresis was applied
according to a published protocol [22]. Briefly, equal amounts of
pdMBL and oxMBL (10 ug protein per well) were run on 4–12%
gradient polyacrylamide gel electrophoresis (PAGE) in native
conditions to determine their oligomeric state. The protein bands
were visualized by Blum’s silver stain [22].
Treatment of Macrophages with pdMBL and oxMBL
Adhered macrophages were incubated for 18 h at 37uC/5%
CO2 in R10 medium containing 20 mg/mL of pdMBL or oxMBL
or R10 only (control).
Efferocytosis of Apoptotic Bronchial Epithelial Cells by
Alveolar and THP-1 Macrophages
Efferocytosis was assessed as previously reported [2,3] with
minor modifications. A final concentration of 20 mg/mL pdMBL
or oxMBL was present during the efferocytosis assays, which were
performed in triplicate. Briefly, a 16 HBE bronchial epithelial cell
line maintained in continuous culture with R10 medium was
induced to apoptosis using a 305 nm UV source (UVP, Upland,
CA, USA), then labelled with 250 nM sytox orange. The
supernatant from each macrophage culture on the 24-well plates
was removed and 500 uL of sytox orange-labelled apoptotic
16 HBE cells added to each well at a 10:1 ratio. Cells were further
incubated at 37uC/5% CO2 for 1.5 hr then supernatant removed.
Following a 5 min incubation with 500 uL ice-cold phosphate
buffered saline (PBS), cells were lifted by gentle continuous
pipetting then transferred to FACS tubes, pelleted by centrifuga-
tion, then stained with 3 mL of CD13 PE-Cy7 for 10 min.
Following a wash with 2 mL of Isoflow (Immunotech/Coulter)
supplemented with 0.5% bovine serum albumin (hereinafter
referred to as wash buffer), cells were pelleted again, resuspended
in 100 mL of wash buffer, 1 mg/mL of trypan blue was added to
quench autofluorescence and 30,000 total events per tube were
acquired immediately using a FACSCanto II Flow Cytometer
(BD).
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Phagocytosis of NTHi by AM and THP-1 Macrophages
NTHi originally isolated from the sputum of an adult with
pneumonia was kindly provided by Susan Pizzutto, Menzies
School of Health Research, Darwin, Northern Territory, Aus-
tralia. The sample was obtained with written consent according to
an ethics approval granted by the Human Research Ethics
Committee of the Northern Territory Department of Health and
Menzies School of Health Research. Frozen stock of NTHi was
defrosted on ice, then 1.366108 CFU of NTHi were washed twice
with ice cold PBS and pelleted by centrifugation. NTHi were then
permeabilized in 400 mL of 70% ethanol at room temperature for
30 min, then washed twice with 0.85% saline and pelleted by
centrifugation at 14,000 rpm/4uC for 5 min. Permeabilized
NTHi resuspended in 0.85% saline were stained with 5 uM sytox
green at room temperature for 5 min, then washed with wash
buffer and pelleted by centrifugation and the concentration
adjusted to 46107 CFU/mL in R10 medium. For the phagocy-
tosis assay, 26107 CFU of sytox green stained NTHi were added
to adhered macrophages pre-treated with pdMBL/oxMBL/
control (media, no MBL) in 24-well plates. Cells were incubated
at 37uC/5% CO2 for 1.5 h, then treated as described for the
efferocytosis assay.
Flow Cytometric Analysis of the Effects of Oxidation on
Macrophage Scavenger Receptors
Multi-parameter flow cytometry was used to assess surface
expression of scavenger receptors in macrophages pre-treated with
pdMBL/oxMBL/control (media, no MBL) as previously reported
[3,11,13].
Immunofluorescence Analysis of the Effects of Oxidation
on Intracellular Macrophage Scavenger Receptor A1
Cytospin preparations of pdMBL/oxMBL/control treated
THP-1 macrophages (,40,000 per spot) were fixed with 2.5%
formalin in phosphate-buffered saline (PBS) for 15 min, washed
twice with 0.05% Tween in Tris-buffered saline pH 7.5 (TBST),
air dried overnight at room temperature, then stored at 220uC.
Before immunostaining, cells were permeabilized for 5 min with
0.1% SDS in PBS, rinsed 3 times with TBST, then blocked with a
serum-free protein solution (Dako A/S, Glostrup, Denmark) for
1 h at room temperature. Cells were incubated overnight with the
primary antibody at 4uC, washed 3 times for 10 min with TBST
on a horizontal shaker, incubated with the Cy3-conjugated
secondary antibody for 1 h at RT and washed 5 times with
TBST as above. For counterstaining of nuclei solution of 49,6-
diamidino-2-phenylindole (DAPI, 200 ng/mL) in PBS was applied
for 15 min before washing. Coverslips were then mounted and
cells were visualized in a Zeiss microscope equipped with HBO
100 illuminating system, AxioCam MRn digital camera and
AxioVision 4.8.1 software (Carl Zeiss GmbH, Goettingen,
Germany). For quantitative analysis, microphotos were taken
from at least 9 optical fields under 40x objective, with selection of
optical fields and focusing carried out in the DAPI channel to
prevent bias. Mean fluorescence intensity in the Cy3 channel was
measured using the particle analysis function of the ImageJ
software (NIH, Bethesda, MD, USA).
Statistical Analyses
Statistical analysis was performed using non-parametric (Krus-
kal Wallis plus post hoc Mann Whitney) or the Wilcoxon test for
comparisons of paired data. Analyses were performed using SPPS
software; p,0.05 was considered significant.
Results
Oxidative Modification of Plasma Derived MBL
Equal amounts of plasma-derived MBL in native state (pdMBL)
or oxidized by AAPH (oxMBL) were run on polyacrylamide gel
electrophoresis (PAGE) under native conditions to measure
changes to oligomer state of MBL. Whereas pdMBL showed both
low molecular weight components and prominent bands repre-
senting higher order quaternary structures, oxMBL was visualised
as only low molecular weight components. Representative results
are shown in Figure 1.
Oxidation Abrogates pdMBL-induced Stimulation of Both
Efferocytosis of Apoptotic Bronchial Epithelial Cells and
Phagocytosis of NTHi by Human Macrophages
The functional capability of pdMBL was firstly assessed in
in vitro assays of efferocytosis and phagocytosis. Pre-treatment of
human alveolar macrophages with pdMBL increased efferocytosis
of apoptotic bronchial epithelial cells and phagocytosis of NTHi, a
pathogen frequently implicated in exacerbations of COPD
(consistent with a previous report of enhanced phagocytosis of S.
aureus and E. coli by pre-incubation of rat Kupffer cells with MBL
[23]). oxMBL did not stimulate but rather showed an inhibitory
effect on both phagocytosis of the pathogen and efferocytosis of
apoptotic cells (Figure 2A, B). Similar results were obtained in
further experiments in which macrophages derived from THP-1
monocytes were tested for stimulatory effects of pdMBL and
inhibitory effects of oxMBL (data not shown).
Flow Cytometric Analysis of the Effects of Oxidation on
Macrophage Scavenger Receptors
The increased macrophage phagocytic capacity observed
following treatment with pdMBL may be the result of mechanisms
involving the up-regulation of pattern recognition receptors
involved in phagocytosis or efferocytosis. Of note, scavenger
receptor A1 (SRA) has been shown to exhibit increased surface
expression in rat Kupffer cells treated with recombinant MBL
[23]. To address this hypothesis multi-parameter flow cytometric
analysis of scavenger receptors on human alveolar macrophages
treated with pdMBL, oxMBL or control (untreated) was
performed. No significant changes in surface expression of
mannose receptor or Colec12 (SCARA4) were detected (data
not shown). Expression of CD204/SRA was significantly in-
creased. There was a significant (p,0.05; Wilcoxon; data pooled
from 7 experiments using BAL-derived alveolar macrophages)
increase in % expression of SRA on macrophages following
Figure 1. Loss of higher-order quaternary structures in oxMBL
vs pdMBL. To mimic high levels of oxidative stress, pdMBL was
exposed to 74 mM of the synthetic oxidizing agent, 2,29-azobis(2-
methylpropionamidine)dihydrochloride (AAPH). Polyacrylamide gel
electrophoresis was then applied to measure changes to MBL by
separating the different MW. Protein samples were loaded 10 ug MBL
per lane for blue native PAGE and visualized with silver stain. Figure
shows a loss of mid-higher order oligomeric structures in oxMBL vs
pdMBL.
doi:10.1371/journal.pone.0098571.g001
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stimulation of cells with pdMBL (Figure 3). Oxidation of MBL
significantly reduced the expression of SRA vs both control and
pdMBL treatment (Figure 3).
Immunofluorescence Analysis of the Effects of Oxidation
on Intracellular Macrophage Scavenger Receptor A1
Immunofluorescence staining revealed a strong stimulatory
effect of pdMBL on intracellular expression of SRA by THP-1
macrophages, which was significantly negated with application of
oxMBL (Figure 4A shows representative images of 3 experiments
that showed similar results). Quantitative measurement of SRA
immunofluorescence in THP-1 macrophages by ImageJ software
demonstrated a significant (p,0.05; Wilcoxon) increase in
immunofluorescence staining of SRA in the presence of pdMBL
(Figure 4B). Oxidation of MBL significantly reduced the expres-
sion of SRA vs both control and pdMBL treatment.
Discussion
It remains unknown why MBL levels in smokers and COPD
patients (and other chronic inflammatory lung diseases) are
reduced in the airways though remain unchanged in the
circulation [8]. A likely reason could be an increased catabolism
in situ in conditions of chronic inflammation. In particular,
neutrophilic release/activation of proteolytic enzymes is implicat-
ed as a key destructive mechanism in COPD [24]. Of the primary
sequence of MBL, the collagen-like domain of MBL has been
identified as susceptible to proteolysis by MMPs, and importantly,
the quaternary structure may protect it from enzymatic attacks
[20]. Oxidative damage has been earlier documented for lung
proteins of the collectin family such as surfactant protein (SP-) A
[25,26] and SP-D [27]; of note significant changes of quaternary
structure were also documented for SP-D in oxidative conditions
both in vitro and in vivo [27]. PdMBL comprises of several
oligomeric forms of which the higher molecular weight forms
are biologically active [19]. Although reducing gels could not be
used for analysis of such forms because of possible breaking of
disulfide bonds which stabilize the quaternary structure, the native
gel electrophoresis revealed a change induced by oxidation in the
mid-to-high molecular weight range, suggesting that oxidative
damage to MBL involves disruption of its higher order quaternary
structure. In oxidative conditions of the airways of smokers and
COPD patients, this may initiate enzymatic breakdown of MBL
by making the collagen-like domain accessible for MMPs attack.
The functional capability of MBL is reported to be dependent
on its oligomerization state. Genetic mutations responsible for
Figure 2. pdMBL but not oxMBL enhanced phagocytosis by human alveolar macrophages. There was a significant increase in
phagocytosis of A. apoptotic bronchial epithelial cells (*, p,0.05; Wilcoxon; data pooled from 9 experiments.) and B. Phagocytosis of NTHi (*, p,0.05;
Wilcoxon; data pooled from 12 experiments) in the presence of pdMBL. Oxidation of MBL significantly reduced the phagocytic ability for both
apoptotic cells and bacteria vs both control and pdMBL treatment.
doi:10.1371/journal.pone.0098571.g002
Figure 3. Oxidation negated the stimulatory effects of pdMBL on BAL-derived alveolar macrophage surface expression of SRA
detected by flow cytometry. A–D. Representative flow cytometry plots showing SRA expression following treatment with pdMBL or oxMBL.
Debris, lymphocytes and cell fragments were firstly excluded based on forward- and side-scatter characteristics then macrophages identified by
positive staining for CD13 and high autofluorescence (not shown). A. Control tube of alveolar macrophages stained with IgG control was included
and the staining patterns used to set quadrant markers for flow cytometric analysis of B. SRA expression in untreated macrophages (13.9%), C. SRA
expression in macrophages treated with plasma-derived MBL (22.6%), D. SRA expression in macrophages treated with oxidized MBL (9.4%). E. There
was a significant increase (*, p,0.05; Wilcoxon; data pooled from 7 experiments using BAL-derived alveolar macrophages) in % expression of SRA in
the presence of pdMBL. Oxidation of MBL abrogated this stimulation effect.
doi:10.1371/journal.pone.0098571.g003
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MBL functional deficiency have long been mapped to amino acid
substitutions in the collagen-like domain which lead to impairment
of the protein oligomerization [28,29]. In line with this concept
and with our findings in previous studies into the pathogenesis of
COPD, here we showed that an oxidative damage involving a loss
of higher order quaternary structure of pdMBL could also lead to
a loss of its functional capability in stimulation of human alveolar
macrophages to phagocytose NTHi or efferocytosis of apoptotic
bronchial epithelial cells. Quantitative analysis of phagocytosis and
efferocytosis in macrophages post treatment with oxidized pdMBL
suggests there was not merely a loss of function but an inhibitory
effect. This raises the very interesting question which requires
further studies to address, that oxidized proteins in the COPD
lung could inhibit efferocytosis and phagocytosis by acting as
competitive ligands to scavenger receptors. Although traditionally
recognized as a mediator of macrophage phagocytosis of
pathogens, MBL is now recognized to regulate the clearance of
apoptotic cells [16,17]. There are several reported macrophage
receptors for MBL that are involved in efferocytosis, including the
CD91-calreticulin complex [16] and CR35/CR1 [30]. We have
previously shown that alveolar macrophages from current-smoker
COPD subjects exhibited reduced expression of several of the
receptors involved in efferocytosis including CD31, CD91 and
hyaluron receptor, compared to healthy never-smoker controls
[3]. However, given our findings of defects in phagocytosis of both
apoptotic cells and bacteria in COPD, we focussed our current
investigations on the effects of MBL on scavenger receptors that
may be involved both in the clearance of apoptotic cells and
NTHi, as this pathogen is present at clinically important levels (.
104 CFU/ml BAL) in the lower airways of ,1/3 COPD patients,
and present in the bronchial tissues of 87% of patients with
exacerbations compared with 33% of stable COPD patients and
0% of healthy controls [31]. These are un-encapsulated H.
influenzae which is an important factor in predicting MBL binding.
The presence of a polysaccharide capsule greatly reduces MBL
binding to bacteria [32].
Our multi-parameter flow cytometric analysis of scavenger
receptors on human alveolar macrophages treated with MBL
detected no significant changes in surface expression of mannose
receptor, Colec12 (SCARA4), Dectin, MFG, CD23 or CD36;
remarkable changes were detected only for SRA. There have been
extensive publications by other authors demonstrating that SRA is
responsible for binding and internalization of bacteria or apoptotic
cells, or dead cell-derived ligands [33–35]. A possible mechanism
for stimulation effects of MBL on efferocytosis and phagocytosis
could be an up-regulated SRA expression in macrophages. Ideally,
the use of Western blot analysis to confirm the increased
expression of SRA detected by flow cytometry and immunoflu-
orescence would have been of interest; however, these were not
possible due to limitations of macrophages numbers from BALs.
Furthermore, our finding was in lines with a previous report on
increased surface expression of SRA in rat Kupffer cells treated
with recombinant MBL [23]. These data suggest that MBL
facilitation of efferocytosis/phagocytosis does not necessarily
involve its opsonisation effect on the target and consequently
bridging the target with macrophages, but rather directly effects
the cell prior to a contact with the target. Consistent with our data,
SP-A, a collectin which has structural homology with MBL, was
reported to stimulate alveolar macrophage phagocytosis of
bacteria through increased cell surface localization of SRA [36].
The precise mechanism for MBL to induce increased expression of
SRA remains yet to be defined. In recent years, immunomodu-
latory effects of MBL on cytokine production have been reported,
and direct interaction between MBL and the TLR2/TLR4
pathway could be a possible mechanism [37–40]. Of relevance
to our findings, a cross-talk between SRA and TLR4 pathway has
also been documented [41,42]. Thus the effects of MBL on SRA
expression and efferocytosis/phagocytosis, together with other
immunomodulatory effects could represent novel functions of this
molecule.
There is a homology in both structure and function between
human and mouse MBL. We have already shown that nebulised
administration of human pdMBL at clinically achievable concen-
trations significantly reduced inflammation and improved effer-
ocytosis in a smoking mouse model, restoring pulmonary
macrophage efferocytic ability and reducing airway inflammation
(evidenced by a significant reduction in WCC and macrophage
numbers to near-normal levels) [12]. In humans, pdMBL has been
designated safe in phase I and II clinical trials [43,44]. No adverse
effects were observed, nor were autoantibodies to MBL present in
samples taken at 24 weeks after the last infusion. These studies
support the application of pdMBL as a useful adjunct therapeutic
strategy for COPD. However, the data from the present
investigation needs to be considered before progressing MBL
therapy to human situations. Our data strongly support the notion
that oxidative stress in the airways of smokers and patients of
COPD is a detrimental factor to both the structure and functions
of MBL in facilitation of efferocytosis of apoptotic cells and
phagocytosis of pathogens. Such effects should be taken into
consideration when designing novel therapeutic approaches for
Figure 4. Increase of SRA expression in THP-1 macrophages
following stimulation with pdMBL but not oxMBL. A. Immuno-
fluorescence staining of SRA (red) in THP-1 macrophages (blue =DAPI).
Images were representative of 3 experiments showing similar results. B.
Quantitative measurement of SRA immunofluorescence in THP-1
macrophages by ImageJ software (MFI6SEM). There was a significant
increase (*, p,0.05; Wilcoxon) in immunofluorescence staining of SRA
in the presence of pdMBL. Oxidation of MBL abrogated this stimulation
effect.
doi:10.1371/journal.pone.0098571.g004
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COPD and possibly other chronic lung diseases where MBL may
play a pathophysiological role.
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